Prof Balram Chowbay
Principal Investigator of the Clinical Pharmacolog
Medical Sciences
Sing Health research
Singapore
Biography
Prof Balram Chowbay is Principal Investigator of the Clinical Pharmacology Laboratory in National Cancer Centre Singapore and Director of the SingHealth Clinical Pharmacology Core. He is an adjunct Professor of Clinical Sciences at both Duke-NUS and NTU School of Chemical and Biological Engineering. He is also head of the Laboratory Science Coordination Core of AMRI and a visiting scientist at KKH. Prof Balram has been actively involved in clinical pharmacology research and early phase clinical trials of anti-cancer agents. His research has largely focused on the applications of pharmacokinetics (PK) and pharmacodynamics (PD) principles to optimize individualized dosage regimens. He has published extensively in international, peer-reviewed journals, particularly in the field of pharmacogenomics and its influence on inter-individual and inter-ethnic variabilities in PK and PD outcomes. His contributions are particularly important in the context of Asian populations. He currently also serves on several review panels and editorial boards.
Research Interest
Understanding pharmacogenomic influences on interethnic variation in the pharmacokinetic/pharmacodynamic of therapeutic agents, design of early phase clinical trials, preclinical clinical pharmacology studies
